Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality and Safety of Screening for Brain Metastases by Gadopiclenol in Patients With Cancer at High Risk of Developing Brain Metastases

NCT07492121 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT07492121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07492121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality and Safety of Screening for Brain Metastases by Gadopiclenol in Patients With Cancer at High Risk of Developing Brain Metastases
Lead sponsor
University of Zurich
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
January 31, 2030
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer metastatic, lung cancer stage iv, melanoma stage iv